Moreover, the expression of TRIM16 was increased in HCC cells with sorafenib treatment, which may thereby reduce the abundance of NFKBIZ, and further hinder the cell apoptosis (Fig. 8E). This evidence concerns the gene TRIM16 and hepatocellular carcinoma.